Skip to main content

Table 2 Main toxicities per patient

From: Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study

Toxicity

Grade 1

Grade 2

Grade 3

Grade 4

Hematological

    

Hemoglobin

2(6.9%)

0

0

0

Neutrophils

5(17.2%)

4(13.8%)

5(17.2%)

2(6.9%)

Platelets

1(3.4%)

1(3.4%)

0

0

Non-hematological

    

Palpitation

1(3.4%)

-

-

-

Edema

2(6.9%)

1(3.4%)

0

0

Fatigue

6(20.7%)

2(6.9%)

0

0

Sweating

4(13.8%)

0

-

-

Weight loss

3(10.3%)

1(3.4%)

0

-

Alopecia

5(17.2%)

2(6.9%)

-

-

Nausea

5(17.2%)

2(6.9%)

1(3.4%)

-

Taste disturbance

1(3.4%)

0

-

-

Vomiting

2(6.9%)

3(10.3%)

0

0

SGOT (AST)

3(10.3%)

0

1(3.4%)

0

SGPT (ALT)

1(3.4%)

1(3.4%)

1(3.4%)

0

Insomnia

3(10.3%)

0

0

-

Arthralgia

2(6.9%)

0

1(3.4%)

0

Headache

2(6.9%)

0

0

0

Myalgia

0

0

1(3.4%)

0